
With COVID-19 and next steps for K-BIO
Back to normal
We will diagnos how ‘With COVID-19’ policy could change our daily life in the future, and what measures to take in the midst of the COVID-19 pandemic.
Conquering the cancer
Introduction of anti-cancer drug development technologies that took a leap forward, such as CAR-T, which opened the way to cure blood cancer, and novel anticancer drug pipelines using the COVID-19 vaccine platform.
K-Bio's survival strategy
We will look into actual ‘M&A’ cases considered to be K-Bio's strategy to enter the global market, and point out key implications.